Financials · YDES

YD Bio Limited (YDES) financials

For fiscal 2025 (ended Dec 31, 2025), YD Bio Limited reported $596.8K of revenue and -$8.31M of net income.

Revenue, FY2025
$596.8K
Revenue growth, YoY
+16.9%
Net income, FY2025
-$8.31M
Net margin
-1392.6%
Free cash flow, FY2025
-$8.04M
EPS, diluted, FY2025
-$0.12
Cash
$6.01M
Total debt
$6.8K
P/S
575.61
Market cap
$343.5M
Annual revenue$596.8K
FY2023FY2025
Annual net income-$8.31M
FY2023FY2025
Annual free cash flow-$8.04M
FY2023FY2025

YDES revenue and earnings growth

YDES revenueFY2025$596.8K

FY YoY
+16.9%

YDES revenue was $596.8K for fiscal 2025 (ended Dec 31, 2025), up 16.9% from fiscal 2024.

YDES net incomeFY2025-$8.31M

YDES net income was -$8.31M for fiscal 2025 (ended Dec 31, 2025), compared with -$1.41M in fiscal 2024.

YDES EPSFY2025-$0.12

YDES diluted EPS was -$0.12 for fiscal 2025 (ended Dec 31, 2025), compared with -$0.02 in fiscal 2024.

YDES free cash flowFY2025-$8.04M

YDES free cash flow was -$8.04M for fiscal 2025 (ended Dec 31, 2025), compared with -$1.30M in fiscal 2024.

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Revenue$596.8K$510.4K$350.1K
Cost of revenue$429.4K$355.0K$196.7K
Gross profit$167.4K$155.4K$153.4K
Research and development$1.60M$491.4K-
Selling, general and admin$3.66M$1.12M$153.1K
Operating income-$5.27M-$1.46M-$9.8K
Interest expense-$772$2.1K
Pre-tax income-$8.31M-$1.39M$17.6K
Income tax-$1.5K$25.1K$4.1K
Net income-$8.31M-$1.41M$13.6K
EPS, basic-$0.12-$0.02$0.00
EPS, diluted-$0.12-$0.02$0.00
Diluted shares66.7M64.7M64.7M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Cash and equivalents$6.01M$3.13M$87.1K
Receivables$167.5K$86.6K-
Inventory$1.88M$37.3K-
Current assets$9.67M$3.47M-
Total assets$13.78M$6.86M-
Current liabilities$1.64M$263.1K-
Long-term debt$6.8K--
Total debt$6.8K--
Total liabilities$16.64M$274.0K-
Shareholders' equity-$2.86M$6.59M$23.0K

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Operating cash flow-$6.60M-$1.22M-$55.7K
Capital expenditures$1.44M$74.9K$290
Free cash flow-$8.04M-$1.30M-$55.9K
Investing cash flow-$1.44M-$2.90M-$290
Financing cash flow$10.87M$7.11M$113.9K

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Revenue growth, YoY16.9%45.8%-
Gross margin28.1%30.4%43.8%
Operating margin-883.3%-286.5%-2.8%
Net margin-1392.6%-276.6%3.9%
Free cash flow margin-1346.6%-254.3%-16.0%
Return on equity--21.4%59.0%
Return on assets-60.3%-20.6%-
Current ratio5.8813.18-

Source: XBRL data YD Bio Limited files with the SEC, latest filing dated Apr 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.

YDES peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
YDES$596.8K+16.9%-$8.31M-1392.6%$343.5M
UNH$449.66B+3.3%$15.88B3.5%$313.53B
ELV$201.83B+3.6%$5.13B2.5%$86.60B
CI$286.32B+6.8%$5.99B2.1%$75.20B
HUM$154.19B+22.0%$1.25B0.8%$46.33B
NTRA$2.91B+37.4%-$164.71M-5.7%$41.98B
CNC$203.90B+9.7%$1.46B0.7%$33.39B
ILMN$4.54B+5.8%$895.00M19.7%$31.75B
LH$14.59B+6.0%$1.00B6.9%$30.11B

YDES FAQ

9 questions
  • What is YDES revenue?
    YD Bio Limited (YDES) reported $596.8K of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 16.9% from the year before.
  • Is YDES profitable?
    No. YD Bio Limited reported a net loss of $8.31M for fiscal 2025 (ended Dec 31, 2025).
  • How much cash and debt does YDES have?
    YD Bio Limited reported $6.01M in cash and cash equivalents and $6.8K of debt on its most recent balance sheet in SEC filings.
  • How fast is YDES revenue growing?
    YD Bio Limited's revenue changed +16.9% in fiscal 2025, to $596.8K.
  • What is YDES gross margin?
    YD Bio Limited's gross profit was $167.4K on $596.8K of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 28.1%.
  • What is YDES free cash flow?
    YD Bio Limited generated -$8.04M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -$6.60M less capital expenditures.
  • What is YDES earnings per share?
    Diluted earnings per share were -$0.12 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.
  • When did YDES last report financial results?
    The latest statements here come from YD Bio Limited's 20-F filed on Apr 30, 2026, covering the period ended Dec 31, 2025.
  • Where does this YDES financial data come from?
    Quantisnow builds these statements from the structured XBRL data YD Bio Limited files with the SEC. It is provided for information only and is not investment advice.